
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $474.6M | $662.4M | $920M | $1.1B | $1B | |
Revenue Growth (YoY) | 38.37% | 39.59% | 38.88% | 22.89% | -9.97% | |
Cost of Revenues | $276M | $376M | $518.2M | $639.3M | $563.2M | |
Gross Profit | $198.6M | $286.4M | $401.8M | $491.3M | $454.7M | |
Gross Profit Margin | 41.85% | 43.24% | 43.67% | 43.46% | 44.67% | |
R&D Expenses | $61.8M | $65.4M | $78.4M | $96.9M | $105.5M | |
Selling, General & Admin | $78.7M | $93.7M | $111.1M | $128.6M | $138.4M | |
Other Inc / (Exp) | $2.3M | -$2.3M | -$6.5M | -$48K | $539K | |
Operating Expenses | $140.5M | $159.1M | $189.4M | $225.5M | $243.9M | |
Operating Income | $58M | $127.3M | $212.4M | $265.8M | $210.8M | |
Net Interest Expenses | $4.5M | $4.6M | $1M | -- | -- | |
EBT. Incl. Unusual Items | $55.9M | $120.4M | $204.9M | $278.6M | $230.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $5.9M | $21.8M | $21.8M | $32.3M | $29.3M | |
Net Income to Company | $50M | $98.7M | $183.1M | $246.3M | $201M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $50M | $98.7M | $183.1M | $246.3M | $201M | |
Basic EPS (Cont. Ops) | $1.50 | $2.94 | $5.54 | $7.52 | $6.17 | |
Diluted EPS (Cont. Ops) | $1.46 | $2.88 | $5.46 | $7.43 | $6.15 | |
Weighted Average Basic Share | $33.3M | $33.6M | $33M | $32.8M | $32.6M | |
Weighted Average Diluted Share | $34.1M | $34.3M | $33.5M | $33.2M | $32.7M | |
EBITDA | $71M | $136.1M | $222.1M | $297M | $251.5M | |
EBIT | $61.1M | $125.3M | $210.5M | $283.9M | $235.7M | |
Revenue (Reported) | $474.6M | $662.4M | $920M | $1.1B | $1B | |
Operating Income (Reported) | $58M | $127.3M | $212.4M | $265.8M | $210.8M | |
Operating Income (Adjusted) | $61.1M | $125.3M | $210.5M | $283.9M | $235.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $132.8M | $203.6M | $254M | $252.4M | $192.6M | |
Revenue Growth (YoY) | 11.59% | 53.34% | 24.77% | -0.65% | -23.7% | |
Cost of Revenues | $76.3M | $113.8M | $150M | $136.3M | $103.8M | |
Gross Profit | $56.4M | $89.8M | $104M | $116.1M | $88.8M | |
Gross Profit Margin | 42.5% | 44.09% | 40.95% | 45.98% | 46.1% | |
R&D Expenses | $15.7M | $17M | $23.8M | $25.7M | $27.1M | |
Selling, General & Admin | $20.4M | $23.9M | $28.9M | $33.9M | $32.5M | |
Other Inc / (Exp) | -$1.2M | -$1.6M | -$1M | -$1.7M | -$309K | |
Operating Expenses | $36.1M | $40.8M | $52.7M | $59.5M | $59.6M | |
Operating Income | $20.4M | $48.9M | $51.4M | $56.5M | $29.2M | |
Net Interest Expenses | $996K | $1.4M | -- | -- | -- | |
EBT. Incl. Unusual Items | $18.2M | $45.9M | $52.9M | $59M | $33.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $1.7M | $4.3M | $5.2M | $7.4M | $4.5M | |
Net Income to Company | $16.5M | $41.6M | $47.7M | $51.6M | $28.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $16.5M | $41.6M | $47.7M | $51.6M | $28.6M | |
Basic EPS (Cont. Ops) | $0.49 | $1.25 | $1.46 | $1.58 | $0.89 | |
Diluted EPS (Cont. Ops) | $0.48 | $1.22 | $1.43 | $1.57 | $0.88 | |
Weighted Average Basic Share | $33.7M | $33.2M | $32.7M | $32.6M | $32.3M | |
Weighted Average Diluted Share | $34.6M | $34M | $33.3M | $32.9M | $32.3M | |
EBITDA | $21.9M | $50.2M | $57.4M | $64.1M | $38.8M | |
EBIT | $19.2M | $47.4M | $54.3M | $60.3M | $34.5M | |
Revenue (Reported) | $132.8M | $203.6M | $254M | $252.4M | $192.6M | |
Operating Income (Reported) | $20.4M | $48.9M | $51.4M | $56.5M | $29.2M | |
Operating Income (Adjusted) | $19.2M | $47.4M | $54.3M | $60.3M | $34.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $488.3M | $733.2M | $970.4M | $1.1B | $958.1M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $278.9M | $413.5M | $554.4M | $625.6M | $530.7M | |
Gross Profit | $209.5M | $319.8M | $416M | $503.3M | $427.4M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $62.9M | $66.7M | $85.2M | $98.8M | $107M | |
Selling, General & Admin | $81.9M | $97.2M | $116.1M | $133.6M | $137M | |
Other Inc / (Exp) | $1.8M | -$2.7M | -$5.9M | -$720K | $1.9M | |
Operating Expenses | $144.8M | $163.9M | $201.2M | $232.4M | $244M | |
Operating Income | $64.7M | $155.9M | $214.8M | $271M | $183.4M | |
Net Interest Expenses | $4.6M | $5.1M | -- | -- | -- | |
EBT. Incl. Unusual Items | $61.8M | $148.1M | $211.9M | $284.7M | $204.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $6.6M | $24.3M | $22.7M | $34.5M | $26.4M | |
Net Income to Company | $55.2M | $123.8M | $189.2M | $250.2M | $178M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $55.2M | $123.8M | $189.2M | $250.2M | $178M | |
Basic EPS (Cont. Ops) | $1.65 | $3.70 | $5.76 | $7.64 | $5.48 | |
Diluted EPS (Cont. Ops) | $1.62 | $3.63 | $5.67 | $7.57 | $5.46 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $77M | $164.5M | $229.2M | $303.8M | $226.2M | |
EBIT | $66.8M | $153.4M | $217.3M | $290M | $209.8M | |
Revenue (Reported) | $488.3M | $733.2M | $970.4M | $1.1B | $958.1M | |
Operating Income (Reported) | $64.7M | $155.9M | $214.8M | $271M | $183.4M | |
Operating Income (Adjusted) | $66.8M | $153.4M | $217.3M | $290M | $209.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $132.8M | $203.6M | $254M | $252.4M | $192.6M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $76.3M | $113.8M | $150M | $136.3M | $103.8M | |
Gross Profit | $56.4M | $89.8M | $104M | $116.1M | $88.8M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $15.7M | $17M | $23.8M | $25.7M | $27.1M | |
Selling, General & Admin | $20.4M | $23.9M | $28.9M | $33.9M | $32.5M | |
Other Inc / (Exp) | -$1.2M | -$1.6M | -$1M | -$1.7M | -$309K | |
Operating Expenses | $36.1M | $40.8M | $52.7M | $59.5M | $59.6M | |
Operating Income | $20.4M | $48.9M | $51.4M | $56.5M | $29.2M | |
Net Interest Expenses | $996K | $1.4M | -- | -- | -- | |
EBT. Incl. Unusual Items | $18.2M | $45.9M | $52.9M | $59M | $33.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $1.7M | $4.3M | $5.2M | $7.4M | $4.5M | |
Net Income to Company | $16.5M | $41.6M | $47.7M | $51.6M | $28.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $16.5M | $41.6M | $47.7M | $51.6M | $28.6M | |
Basic EPS (Cont. Ops) | $0.49 | $1.25 | $1.46 | $1.58 | $0.89 | |
Diluted EPS (Cont. Ops) | $0.48 | $1.22 | $1.43 | $1.57 | $0.88 | |
Weighted Average Basic Share | $33.7M | $33.2M | $32.7M | $32.6M | $32.3M | |
Weighted Average Diluted Share | $34.6M | $34M | $33.3M | $32.9M | $32.3M | |
EBITDA | $21.9M | $50.2M | $57.4M | $64.1M | $38.8M | |
EBIT | $19.2M | $47.4M | $54.3M | $60.3M | $34.5M | |
Revenue (Reported) | $132.8M | $203.6M | $254M | $252.4M | $192.6M | |
Operating Income (Reported) | $20.4M | $48.9M | $51.4M | $56.5M | $29.2M | |
Operating Income (Adjusted) | $19.2M | $47.4M | $54.3M | $60.3M | $34.5M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $203.5M | $294.9M | $185.6M | $167.3M | $123.5M | |
Short Term Investments | -- | -- | $246.6M | $338.9M | $447.8M | |
Accounts Receivable, Net | $86.9M | $104.4M | $169.8M | $218M | $203.1M | |
Inventory | $161.1M | $195M | $242.4M | $306.5M | $282.2M | |
Prepaid Expenses | -- | -- | -- | -- | $6.4M | |
Other Current Assets | $19.4M | $24.9M | $33.3M | $49.4M | $60.5M | |
Total Current Assets | $470.8M | $619.2M | $877.6M | $1.1B | $1.1B | |
Property Plant And Equipment | $54.9M | $63.5M | $69.8M | $101.3M | $98.8M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $41.1M | $35.1M | $34.5M | $47.2M | $58.1M | |
Total Assets | $624.6M | $753.2M | $1B | $1.3B | $1.3B | |
Accounts Payable | $24M | $38M | $62.3M | $54.4M | $46.9M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $756K | $979K | $1.2M | $1.5M | $1.3M | |
Other Current Liabilities | $8.9M | $12.6M | $12.9M | $12.8M | $26M | |
Total Current Liabilities | $84.4M | $150.1M | $248.1M | $285.1M | $207.5M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $143M | $214.3M | $346.4M | $417.1M | $336M | |
Common Stock | $34K | $33K | $33K | $33K | $32K | |
Other Common Equity Adj | $3.4M | $1.8M | -$2M | -$1.8M | -$6.2M | |
Common Equity | $481.6M | $539M | $667.3M | $864.9M | $1B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $481.6M | $539M | $667.3M | $864.9M | $1B | |
Total Liabilities and Equity | $624.6M | $753.2M | $1B | $1.3B | $1.3B | |
Cash and Short Terms | $203.5M | $294.9M | $432.2M | $506.1M | $571.3M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $206.8M | $297.1M | $164.5M | $134M | $184M | |
Short Term Investments | -- | -- | $280.2M | $396.2M | $403.1M | |
Accounts Receivable, Net | $75.9M | $119M | $189.6M | $208.5M | $164.9M | |
Inventory | $174.4M | $203.8M | $262.1M | $312.2M | $295.9M | |
Prepaid Expenses | -- | -- | -- | -- | $6.6M | |
Other Current Assets | $22.5M | $28.7M | $38.1M | $54.5M | $59.5M | |
Total Current Assets | $479.6M | $648.7M | $934.4M | $1.1B | $1.1B | |
Property Plant And Equipment | $54.9M | $63.8M | $69.3M | $98.9M | $100.8M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $39.9M | $33.4M | $40.7M | $47.7M | $56.5M | |
Total Assets | $629.3M | $782.2M | $1.1B | $1.3B | $1.3B | |
Accounts Payable | $40.5M | $50.8M | $60.5M | $39.9M | $39M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $809K | $1M | $1.3M | $1.5M | $1.4M | |
Other Current Liabilities | $8.8M | $15.7M | $12.3M | $12.9M | $22.9M | |
Total Current Liabilities | $83.9M | $147.5M | $267.9M | $276.6M | $200.4M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $141.6M | $222.9M | $378M | $404.9M | $313.4M | |
Common Stock | $34K | $33K | $33K | $33K | $32K | |
Other Common Equity Adj | $2.1M | $588K | -$1.9M | -$3.6M | -$5.5M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $487.7M | $559.3M | $701.8M | $901.7M | $1B | |
Total Liabilities and Equity | $629.3M | $782.2M | $1.1B | $1.3B | $1.3B | |
Cash and Short Terms | $206.8M | $297.1M | $444.7M | $530.2M | $587.1M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $50M | $98.7M | $183.1M | $246.3M | $201M | |
Depreciation & Amoritzation | $9.9M | $10.8M | $11.6M | $13.1M | $15.8M | |
Stock-Based Compensation | $10.5M | $12.1M | $13.4M | $18.3M | $21M | |
Change in Accounts Receivable | -$1.4M | -$18.1M | -$67.3M | -$50.8M | $6.9M | |
Change in Inventories | -$17.7M | -$39M | -$58.4M | -$70M | $5.9M | |
Cash From Operations | $69.7M | $150.2M | $215.6M | $156.9M | $140.8M | |
Capital Expenditures | $7.4M | $8.7M | $10.7M | $20.7M | $12.2M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$7.3M | -$8.7M | -$257.3M | -$100.9M | -$108.7M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$399K | -$763K | -$987K | -$1.2M | -$1.5M | |
Repurchase of Common Stock | -$7.5M | -$50M | -$57.5M | -$52.5M | -$60.5M | |
Other Financing Activities | -$3.9M | -$6.6M | -$9.9M | -$16.6M | -$11.6M | |
Cash From Financing | -$2.4M | -$52.5M | -$65.5M | -$68.3M | -$71.2M | |
Beginning Cash (CF) | $146.5M | $204.2M | $295.7M | $186.3M | $174M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $60.1M | $89M | -$107.1M | -$12.3M | -$39.1M | |
Ending Cash (CF) | $204.2M | $295.7M | $186.3M | $174M | $131.1M | |
Levered Free Cash Flow | $62.3M | $141.5M | $204.9M | $136.2M | $128.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $16.5M | $41.6M | $47.7M | $51.6M | $28.6M | |
Depreciation & Amoritzation | $2.6M | $2.8M | $3.1M | $3.8M | $4.3M | |
Stock-Based Compensation | $2.4M | $2.7M | $3.2M | $4.7M | $4.9M | |
Change in Accounts Receivable | $10.4M | -$15.2M | -$20.8M | $7M | $38.6M | |
Change in Inventories | -$16.5M | -$11.5M | -$21.1M | -$11.4M | -$12.4M | |
Cash From Operations | $15.1M | $25.8M | $34.6M | $42.2M | $39.8M | |
Capital Expenditures | $1.3M | $1.5M | $2.2M | $1.6M | $5M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$1.3M | -$1.5M | -$33M | -$55.7M | $40.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$175K | -$229K | -$289K | -$357K | -$349K | |
Repurchase of Common Stock | -$11.6M | -$20M | -$12.5M | -$15M | -$18.2M | |
Other Financing Activities | -$2.4M | -$3.3M | -$3.9M | -$2.7M | -$1.6M | |
Cash From Financing | -$11.7M | -$23.1M | -$16.7M | -$18.1M | -$20.1M | |
Beginning Cash (CF) | $204.2M | $295.7M | $186.3M | $174M | $131.1M | |
Foreign Exchange Rate Adjustment | $1.2M | $1M | -$55K | -$1.8M | $292K | |
Additions / Reductions | $2.1M | $1.2M | -$15.2M | -$31.5M | $60.2M | |
Ending Cash (CF) | $207.5M | $297.9M | $171.1M | $140.6M | $191.5M | |
Levered Free Cash Flow | $13.8M | $24.3M | $32.3M | $40.6M | $34.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $55.2M | $123.8M | $189.2M | $250.2M | $178M | |
Depreciation & Amoritzation | $10.2M | $11M | $11.9M | $13.7M | $16.3M | |
Stock-Based Compensation | $11.2M | $12.4M | $13.9M | $19.8M | $21.2M | |
Change in Accounts Receivable | -$10.2M | -$43.8M | -$72.8M | -$23M | $38.5M | |
Change in Inventories | -$36.1M | -$34M | -$68M | -$60.3M | $5M | |
Cash From Operations | $45.1M | $160.9M | $224.4M | $164.5M | $138.4M | |
Capital Expenditures | $7.5M | $8.9M | $11.4M | $20M | $15.5M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$7.3M | -$8.9M | -$288.8M | -$123.5M | -$12.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$574K | -$817K | -$1M | -$1.3M | -$1.5M | |
Repurchase of Common Stock | -$11.6M | -$58.4M | -$50M | -$55M | -$63.7M | |
Other Financing Activities | -$5.1M | -$7.5M | -$10.5M | -$15.4M | -$10.4M | |
Cash From Financing | -$9.9M | -$63.9M | -$59.1M | -$69.7M | -$73.2M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $27.9M | $88.1M | -$123.5M | -$28.6M | $52.6M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $37.6M | $152M | $213M | $144.5M | $122.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $16.5M | $41.6M | $47.7M | $51.6M | $28.6M | |
Depreciation & Amoritzation | $2.6M | $2.8M | $3.1M | $3.8M | $4.3M | |
Stock-Based Compensation | $2.4M | $2.7M | $3.2M | $4.7M | $4.9M | |
Change in Accounts Receivable | $10.4M | -$15.2M | -$20.8M | $7M | $38.6M | |
Change in Inventories | -$16.5M | -$11.5M | -$21.1M | -$11.4M | -$12.4M | |
Cash From Operations | $15.1M | $25.8M | $34.6M | $42.2M | $39.8M | |
Capital Expenditures | $1.3M | $1.5M | $2.2M | $1.6M | $5M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$1.3M | -$1.5M | -$33M | -$55.7M | $40.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$175K | -$229K | -$289K | -$357K | -$349K | |
Repurchase of Common Stock | -$11.6M | -$20M | -$12.5M | -$15M | -$18.2M | |
Other Financing Activities | -$2.4M | -$3.3M | -$3.9M | -$2.7M | -$1.6M | |
Cash From Financing | -$11.7M | -$23.1M | -$16.7M | -$18.1M | -$20.1M | |
Beginning Cash (CF) | $204.2M | $295.7M | $186.3M | $174M | $131.1M | |
Foreign Exchange Rate Adjustment | $1.2M | $1M | -$55K | -$1.8M | $292K | |
Additions / Reductions | $2.1M | $1.2M | -$15.2M | -$31.5M | $60.2M | |
Ending Cash (CF) | $207.5M | $297.9M | $171.1M | $140.6M | $191.5M | |
Levered Free Cash Flow | $13.8M | $24.3M | $32.3M | $40.6M | $34.8M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.